DK1467993T3 - Fremgangsmåde til fremstilling af scopinestere - Google Patents

Fremgangsmåde til fremstilling af scopinestere

Info

Publication number
DK1467993T3
DK1467993T3 DK02796735T DK02796735T DK1467993T3 DK 1467993 T3 DK1467993 T3 DK 1467993T3 DK 02796735 T DK02796735 T DK 02796735T DK 02796735 T DK02796735 T DK 02796735T DK 1467993 T3 DK1467993 T3 DK 1467993T3
Authority
DK
Denmark
Prior art keywords
esters
formula
quaternized scopine
quaternized
scopine
Prior art date
Application number
DK02796735T
Other languages
English (en)
Inventor
Joerg Brandenburg
Waldemar Pfrengle
Werner Rall
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1467993T3 publication Critical patent/DK1467993T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
DK02796735T 2002-01-12 2002-12-24 Fremgangsmåde til fremstilling af scopinestere DK1467993T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10200943A DE10200943A1 (de) 2002-01-12 2002-01-12 Verfahren zur Herstellung von Scopinestern
PCT/EP2002/014756 WO2003057694A1 (de) 2002-01-12 2002-12-24 Verfahren zur herstellung von scopinestern

Publications (1)

Publication Number Publication Date
DK1467993T3 true DK1467993T3 (da) 2008-11-10

Family

ID=7711974

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02796735T DK1467993T3 (da) 2002-01-12 2002-12-24 Fremgangsmåde til fremstilling af scopinestere

Country Status (31)

Country Link
US (1) US6747154B2 (da)
EP (2) EP1972626A3 (da)
JP (1) JP5134756B2 (da)
KR (1) KR100929503B1 (da)
CN (1) CN100406456C (da)
AT (1) ATE404557T1 (da)
AU (1) AU2002361218B2 (da)
BR (1) BR0215493A (da)
CA (1) CA2471755C (da)
CO (1) CO5601006A2 (da)
CY (1) CY1108471T1 (da)
DE (2) DE10200943A1 (da)
DK (1) DK1467993T3 (da)
EA (1) EA007230B1 (da)
EC (1) ECSP045182A (da)
ES (1) ES2312655T3 (da)
HK (1) HK1073847A1 (da)
HR (1) HRP20040623B1 (da)
HU (1) HU226665B1 (da)
IL (2) IL162416A0 (da)
ME (1) MEP51208A (da)
MX (1) MXPA04006677A (da)
NO (1) NO328825B1 (da)
NZ (1) NZ534339A (da)
PL (1) PL208132B1 (da)
PT (1) PT1467993E (da)
RS (1) RS50771B (da)
SI (1) SI1467993T1 (da)
UA (1) UA78753C2 (da)
WO (1) WO2003057694A1 (da)
ZA (1) ZA200403852B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10216427A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
CA2495275C (en) * 2002-08-14 2012-04-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic agent
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
EP2067779B9 (de) * 2003-11-03 2013-10-16 Boehringer Ingelheim International GmbH Tiotropiumsalze, Verfahren zu deren Herstellung und Arzneimittelformulierungen diese enthaltend
EP2336127A1 (de) * 2003-11-03 2011-06-22 Boehringer Ingelheim International GmbH Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE102004041253A1 (de) 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
WO2006117299A2 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
MX2007015997A (es) * 2005-06-15 2008-03-07 Boehringer Ingelheim Int Procedimiento para preparar nuevas sales de tiotropio, nuevas sales de tiotropio como tales y composiciones farmaceuticas de las mismas.
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
US20070088160A1 (en) * 2005-08-15 2007-04-19 Thomas Krueger Process for the manufacturing of betamimetics
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
EP1997819A1 (de) 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopinestern
US20110028508A1 (en) * 2008-01-10 2011-02-03 Gemerocs [UK] Limited Novel process for the preparation of scopine esters
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
AU2010280497B2 (en) 2009-08-07 2015-10-22 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
TR201002520A2 (tr) * 2010-04-01 2010-05-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür imalat metodu.
US8957209B2 (en) 2010-04-01 2015-02-17 Mahmut Bilgic Methods for the synthesis of tiotropium bromide
TR201005222A2 (tr) * 2010-04-01 2011-10-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür sentez yöntemi
TR201005221A2 (tr) * 2010-04-01 2012-01-23 Bi̇lgi̇ç Mahmut Geliştirilmiş sentez metodu.
ITRM20110508A1 (it) 2011-09-27 2013-03-28 Lusochimica Spa Processo per la preparazione degli esteri della scopina.
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
CZ304808B6 (cs) 2012-03-16 2014-11-05 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu a jeho nová forma
CZ305012B6 (cs) 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
ATE222587T1 (de) * 1994-04-19 2002-09-15 Neurosearch As TROPAN-2-ALDOXIMDERIVATE ALS NEUROTRANSMITTER ßREUPTAKEß INHIBITOREN
DE19515625C2 (de) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
US6153618A (en) * 1996-10-11 2000-11-28 Chiron Corporation Inhibitors of glycogen synthase 3 kinase
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate

Also Published As

Publication number Publication date
EA200400875A1 (ru) 2004-12-30
WO2003057694A1 (de) 2003-07-17
CA2471755A1 (en) 2003-07-17
NO328825B1 (no) 2010-05-25
EP1467993B1 (de) 2008-08-13
HK1073847A1 (en) 2005-10-21
US6747154B2 (en) 2004-06-08
US20030232993A1 (en) 2003-12-18
KR100929503B1 (ko) 2009-12-03
JP2005519890A (ja) 2005-07-07
CN1610680A (zh) 2005-04-27
HRP20040623A2 (en) 2005-04-30
MXPA04006677A (es) 2004-10-04
KR20040072715A (ko) 2004-08-18
EP1467993A1 (de) 2004-10-20
IL162416A (en) 2010-06-30
NO20043341L (no) 2004-08-11
ZA200403852B (en) 2005-06-22
DE50212650D1 (de) 2008-09-25
CY1108471T1 (el) 2014-04-09
AU2002361218A1 (en) 2003-07-24
ECSP045182A (es) 2004-08-27
HRP20040623B1 (en) 2012-09-30
CN100406456C (zh) 2008-07-30
NZ534339A (en) 2005-04-29
PL208132B1 (pl) 2011-03-31
IL162416A0 (en) 2005-11-20
HU226665B1 (en) 2009-06-29
ATE404557T1 (de) 2008-08-15
RS50771B (sr) 2010-08-31
PT1467993E (pt) 2008-09-03
MEP51208A (en) 2011-05-10
EP1972626A2 (de) 2008-09-24
BR0215493A (pt) 2004-12-28
JP5134756B2 (ja) 2013-01-30
ES2312655T3 (es) 2009-03-01
HUP0402604A2 (hu) 2005-04-28
HUP0402604A3 (en) 2008-05-28
EP1972626A3 (de) 2008-10-01
CO5601006A2 (es) 2006-01-31
UA78753C2 (en) 2007-04-25
CA2471755C (en) 2011-02-08
RS59404A (en) 2007-04-10
AU2002361218B2 (en) 2008-04-24
DE10200943A1 (de) 2003-07-24
PL369126A1 (en) 2005-04-18
SI1467993T1 (sl) 2009-02-28
EA007230B1 (ru) 2006-08-25

Similar Documents

Publication Publication Date Title
DK1467993T3 (da) Fremgangsmåde til fremstilling af scopinestere
ES2237144T3 (es) Nuevos derivados de cefalotaxano y procedimiento para su preparacion.
CA2738706C (en) Synthesis of boronic ester and acid compounds
PT94187B (pt) Metodo para a preparacao de taxol
MA29464B1 (fr) Methode de preparation d&#39;acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues
DK0540356T3 (da) Fremgangsmåde til fremstilling af visse substituerede biphenyltetrazolderivater
WO2002085849A3 (en) Process to prepare oxazolidinones
HUE032259T2 (en) A new process for the preparation of thiotropium salts
Hirama et al. Enantiospecific syntheses of trifunctional (R)-3-hydroxy esters by baker's yeast reduction
JP2006516273A5 (da)
DK1515962T3 (da) Fremgangsmåde til fremstilling af dioxaneddikesyreestere
ES2206738T3 (es) Procedimientos e intermediarios para la preparacion de derivados sustituidos de cromanol.
CA2451573A1 (en) Technical process for the manufacture of tropenol
WO2006031788A3 (en) Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
SU1169527A3 (ru) Способ получени хлорформиатов @ - @ -алкиловых эфиров @ - @ - @ -алкилтартроновой кислоты
DD222315A5 (de) Verfahren zur herstellung von halogenmethyl-1,1-dioxopenicillan-oyloxymethyl-carbonaten
EP1369408A4 (en) PROCESS FOR PREPARING BICYCLOCARBOXYLIC ACID DERIVATIVES
KR890004693B1 (ko) 아미노사이클로펜탄알케노산의 제조방법
HU0001727D0 (en) Novel 1-aza-2-alkyl-6-aryl-cycloalkane compounds, process for producing them and medicaments containing the same
JP4404186B2 (ja) ビタミンd中間体−a環部シクロヘキサン誘導体の製造法
KR20020025212A (ko) 시클로헥산 카르복실산의 제조 방법
CA1111865A (en) Intermediate in the preparation of cyclopropylcarboxylate esters and process for its manufacture
ZA916013B (en) Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
Jones Attempted Separation of 8-Fluoroquininone (96a) and 8-Fluoroquinidinone (96b) with D-Tartaric Acid
JPS6483039A (en) Meta-substituted benzaldehyde acetal derivative